Varicella vaccine strain infection in a non-immunocompromised patient. A case report and review of literature.

Abstract	Varicella live attenuated vaccine led to a significant reduction in morbidity and mortality from varicella zoster disease. Vaccine adverse effects are mostly mild. Immunosuppression is the main risk factor for severe varicella. Risk factors for disease following vaccination are less studied. We report a 12-month-old infant with no T-cell immunodeficiency who developed severe varicella infection by vaccine strain.
Authors	Rana Swed-Tobia, Imad Kassis, Suhair Hanna, Moran Szwarcwort-Cohen, Sara Dovrat, Halima Dabaja-Younis
Journal	Human vaccines & immunotherapeutics (Hum Vaccin Immunother) Vol. 17 Issue 4 Pg. 1129-1131 (04 03 2021) ISSN: 2164-554X [Electronic] United States
PMID	32946310 (Publication Type: Case Reports, Journal Article, Review)
Chemical References	Chickenpox Vaccine Vaccines, Attenuated
Topics	Chickenpox Chickenpox Vaccine Herpes Zoster Herpesvirus 3, Human Humans Infant Vaccines, Attenuated

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!